213 related articles for article (PubMed ID: 27863568)
1. Molecular Imaging and Precision Medicine in Head and Neck Cancer.
Mena E; Thippsandra S; Yanamadala A; Redy S; Pattanayak P; Subramaniam RM
PET Clin; 2017 Jan; 12(1):7-25. PubMed ID: 27863568
[TBL] [Abstract][Full Text] [Related]
2. The Current and Evolving Role of PET in Personalized Management of Lung Cancer.
Mena E; Yanamadala A; Cheng G; Subramaniam RM
PET Clin; 2016 Jul; 11(3):243-59. PubMed ID: 27321029
[TBL] [Abstract][Full Text] [Related]
3. The potential role of non-FDG-PET in the management of head and neck cancer.
Heuveling DA; de Bree R; van Dongen GA
Oral Oncol; 2011 Jan; 47(1):2-7. PubMed ID: 21109481
[TBL] [Abstract][Full Text] [Related]
4. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
5. Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.
Sheikhbahaei S; Mena E; Pattanayak P; Taghipour M; Solnes LB; Subramaniam RM
PET Clin; 2017 Jan; 12(1):105-118. PubMed ID: 27863562
[TBL] [Abstract][Full Text] [Related]
6. Emerging Opportunities for Digital PET/CT to Advance Locoregional Therapy in Head and Neck Cancer.
Wright CL; Washington IR; Bhatt AD; Knopp MV
Semin Radiat Oncol; 2019 Apr; 29(2):93-101. PubMed ID: 30827458
[TBL] [Abstract][Full Text] [Related]
7. Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?
Basu B; Basu S
Cancer Biother Radiopharm; 2016 Apr; 31(3):75-84. PubMed ID: 27093341
[TBL] [Abstract][Full Text] [Related]
8. Precision Medicine and PET/Computed Tomography in Melanoma.
Mena E; Sanli Y; Marcus C; Subramaniam RM
PET Clin; 2017 Oct; 12(4):449-458. PubMed ID: 28867115
[TBL] [Abstract][Full Text] [Related]
9. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers.
Menda Y; Graham MM
Semin Nucl Med; 2005 Oct; 35(4):214-9. PubMed ID: 16150243
[TBL] [Abstract][Full Text] [Related]
10. Molecular Imaging and Precision Medicine in Breast Cancer.
Chudgar AV; Mankoff DA
PET Clin; 2017 Jan; 12(1):39-51. PubMed ID: 27863565
[TBL] [Abstract][Full Text] [Related]
11. PET/CT in Head-neck Malignancies: The Implications for Personalized Clinical Practice.
Wassef HR; Hanna N; Colletti P
PET Clin; 2016 Jul; 11(3):219-32. PubMed ID: 27321027
[TBL] [Abstract][Full Text] [Related]
12. The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
Kutler DI; Wong RJ; Schoder H; Kraus DH
Curr Opin Otolaryngol Head Neck Surg; 2006 Apr; 14(2):73-81. PubMed ID: 16552262
[TBL] [Abstract][Full Text] [Related]
13. Analysis of pairwise correlations in multi-parametric PET/MR data for biological tumor characterization and treatment individualization strategies.
Leibfarth S; Simoncic U; Mönnich D; Welz S; Schmidt H; Schwenzer N; Zips D; Thorwarth D
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1199-208. PubMed ID: 26872789
[No Abstract] [Full Text] [Related]
14. [The role and limitations of FDG-PET in head and neck cancer].
Horiuchi C; Tsukuda M; Matsuda H; Taguchi T; Nishimura G; Takahashi M; Watanabe M; Komatsu M
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2542-6. PubMed ID: 20009454
[TBL] [Abstract][Full Text] [Related]
15. Non-18F-FDG PET/CT in the management of patients affected by HNC: state-of-the-art.
Quartuccio N; Caobelli F; Di Mauro F; Cammaroto G;
Nucl Med Commun; 2016 Sep; 37(9):891-8. PubMed ID: 27139114
[TBL] [Abstract][Full Text] [Related]
16. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.
Platzek I
PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244
[TBL] [Abstract][Full Text] [Related]
17. Role of positron emission tomography/computed tomography (PET/CT) in head and neck cancer.
Escott EJ
Radiol Clin North Am; 2013 Sep; 51(5):881-93. PubMed ID: 24010911
[TBL] [Abstract][Full Text] [Related]
18. Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond.
Porceddu SV; Burmeister BH; Hicks RJ
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1221-38, ix-x. PubMed ID: 19010270
[TBL] [Abstract][Full Text] [Related]
19. Designing and Developing PET-Based Precision Model in Thyroid Carcinoma: The Potential Avenues for a Personalized Clinical Care.
Basu S; Parghane RV
PET Clin; 2017 Jan; 12(1):27-37. PubMed ID: 27863564
[TBL] [Abstract][Full Text] [Related]
20. Molecular Imaging and Precision Medicine in Prostate Cancer.
Ceci F; Fiorentino M; Castellucci P; Fanti S
PET Clin; 2017 Jan; 12(1):83-92. PubMed ID: 27863569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
